Abstract

Activation of microglia is a prominent pathological feature in tauopathies, including Alzheimer’s disease. How microglia activation contributes to tau toxicity remains largely unknown. Here we show that nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) signaling, activated by tau, drives microglial-mediated tau propagation and toxicity. Constitutive activation of microglial NF-κB exacerbated, while inactivation diminished, tau seeding and spreading in young PS19 mice. Inhibition of NF-κB activation enhanced the retention while reduced the release of internalized pathogenic tau fibrils from primary microglia and rescued microglial autophagy deficits. Inhibition of microglial NF-κB in aged PS19 mice rescued tau-mediated learning and memory deficits, restored overall transcriptomic changes while increasing neuronal tau inclusions. Single cell RNA-seq revealed that tau-associated disease states in microglia were diminished by NF-κB inactivation and further transformed by constitutive NF-κB activation. Our study establishes a role for microglial NF-κB signaling in mediating tau spreading and toxicity in tauopathy.

Wang et al show that microglial NF-κB activation is essential for tau spreading and tau-mediated spatial learning and memory deficits in tauopathy mice. Inactivation of NF-κB reversed tau associated microglial states and rescued autophagy deficits.

Details

Title
Microglial NF-κB drives tau spreading and toxicity in a mouse model of tauopathy
Author
Wang, Chao 1   VIAFID ORCID Logo  ; Li, Fan 2 ; Khawaja, Rabia R 3 ; Liu, Bangyan 2 ; Zhan Lihong 1 ; Kodama Lay 2   VIAFID ORCID Logo  ; Chin, Marcus 1   VIAFID ORCID Logo  ; Li, Yaqiao 1 ; Le, David 1 ; Zhou Yungui 1 ; Condello Carlo 4   VIAFID ORCID Logo  ; Grinberg, Lea T 5   VIAFID ORCID Logo  ; Seeley, William W 5 ; Miller, Bruce L 5 ; Mok Sue-Ann 6   VIAFID ORCID Logo  ; Gestwicki, Jason E 7   VIAFID ORCID Logo  ; Cuervo, Ana Maria 3   VIAFID ORCID Logo  ; Luo Wenjie 2   VIAFID ORCID Logo  ; Gan, Li 8   VIAFID ORCID Logo 

 University of California, San Francisco, Gladstone Institutes, San Francisco, USA (GRID:grid.266102.1) (ISNI:0000 0001 2297 6811) 
 Brain and Mind Research Institute, Weill Cornell Medicine, Helen and Robert Appel Alzheimer’s Disease Institute, New York, USA (GRID:grid.5386.8) (ISNI:000000041936877X) 
 Albert Einstein College of Medicine, Department of Developmental and Molecular Biology, Bronx, USA (GRID:grid.251993.5) (ISNI:0000000121791997) 
 University of California, San Francisco, Institute for Neurodegenerative Diseases, San Francisco, USA (GRID:grid.266102.1) (ISNI:0000 0001 2297 6811); University of California, San Francisco, Department of Neurology, San Francisco, USA (GRID:grid.266102.1) (ISNI:0000 0001 2297 6811) 
 University of California, San Francisco, Department of Neurology, San Francisco, USA (GRID:grid.266102.1) (ISNI:0000 0001 2297 6811); University of California, San Francisco, Memory and Aging Center, San Francisco, USA (GRID:grid.266102.1) (ISNI:0000 0001 2297 6811) 
 Faculty of Medicine and Dentistry, University of Alberta, Department of Biochemistry, Edmonton, Canada (GRID:grid.17089.37) (ISNI:0000 0001 2190 316X) 
 University of California, San Francisco, Institute for Neurodegenerative Diseases, San Francisco, USA (GRID:grid.266102.1) (ISNI:0000 0001 2297 6811); University of California, San Francisco, Department of Pharmaceutical Chemistry, San Francisco, USA (GRID:grid.266102.1) (ISNI:0000 0001 2297 6811) 
 University of California, San Francisco, Gladstone Institutes, San Francisco, USA (GRID:grid.266102.1) (ISNI:0000 0001 2297 6811); Brain and Mind Research Institute, Weill Cornell Medicine, Helen and Robert Appel Alzheimer’s Disease Institute, New York, USA (GRID:grid.5386.8) (ISNI:000000041936877X) 
Publication year
2022
Publication date
2022
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2649422632
Copyright
© The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.